News Archive
The GW Cancer Center is pleased to announce the appointment of Pavani Chalasani, MD, MPH, to serve as the new director of the Division of Hematology and Medical Oncology at the GW Medical Faculty Associates.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the selection of Hematology and Oncology Fellows, Walaa Aldhahri, MBBS, and Zoë McKinnell, MD, as the 2023 Albert L. Tucker and Elizabeth T. Tucker Postdoctoral Fellowship awardees.
A new combination drug treatment showed promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.
Elmer Huerta, MD, MPH, director of the Cancer Preventorium at the George Washington University Cancer Center, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.
Julie E. Bauman, MD, MPH, director of the GW Cancer Center, associate dean of cancer and professor of medicine, was featured in the article “Cancer Vaccine Hunt Makes Progress, Finally,” by Lisa Jarvis in the Jan. 3 edition of the Washington Post. Bauman discussed the traction MRNA vaccine…
Joy West had stage three vocal cord cancer. She was treated at the GW Cancer Center and is now cancer free. Hear her inspiring story.
Announcement (Jan. 26, 2022) — The George Washington University (GW) is pleased to announce that Julie E. Bauman, MD, MPH, will join its academic medical enterprise to serve as the director of the GW Cancer Center. In this role, Bauman will build on the momentum of the last five years to enhance…
Claudia was 20 weeks pregnant when she was diagnosed with colon cancer. The doctors at GW Hospital treated her cancer and helped her deliver a healthy baby girl.
Jeffrey Gray is a prostate cancer survivor, thanks to the minimally invasive surgery he received from urology specialist Michael J. Whalen, MD, at the GW Cancer Center. Now he’s back to doing the things he loves.
For patients diagnosed with skin cancer, particularly basal cell and squamous cell carcinoma, one of the best treatment options can be Mohs surgery, a tissue-sparing, tumor-removal procedure.